Label Changes for:
INVANZ (ertapenem) Injection, 1 gm
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- depressed level of consciousness
- includes altered mental status (including aggression, delirium), dyskinesia, myoclonus, and tremor